TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO. Stock

Certificat

DE000SF8RCS7

Delayed Deutsche Boerse AG 05:21:49 2024-06-03 am EDT
4.07 EUR -0.25% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO.
1 month-10.92%
3 months-8.31%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-03 4.07 -0.25%
24-05-31 4.08 +0.49%
24-05-30 4.06 -2.40%
24-05-29 4.16 +0.24%
24-05-28 4.15 -5.47%

Delayed Quote Deutsche Boerse AG

Last update June 03, 2024 at 05:21 am EDT

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SF8RCS
ISINDE000SF8RCS7
Date issued 2021-10-04
Strike 81.35 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.25
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 4.86
Lowest since issue 0.13
Spread 0.06
Spread %1.45%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5 USD
Average target price
141.9 USD
Spread / Average Target
+13.01%
Consensus